Home › Meningioma › Ohio › Cincinnati
Meningioma clinical trials in Cincinnati, OH
3 studies for Meningioma are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- and 3 more
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- Mayfield Brain and Spine, Cincinnati
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RecruitingPhase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Meningioma trials in other cities
- New York City, NY8 studies
- Miami, FL7 studies
- Boston, MA6 studies
- Columbus, OH6 studies
- San Francisco, CA5 studies
- San Diego, CA5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Phoenix, AZ4 studies
- Arlington, VA4 studies
- Houston, TX4 studies
- Detroit, MI4 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer35 studies
- Cancer (all types)27 studies
- Breast Cancer25 studies
- Heart Failure24 studies
- Colorectal Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Lung Cancer19 studies
- Obesity19 studies
- Prostate Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.